Srinivas Ajjarapu
- Pharmaceutical Science top 5%
- Drug Solubulity and Delivery Systems 4
- Advancements in Transdermal Drug Delivery 3
- Advanced Drug Delivery Systems 2
-
- Nanoparticle-Based Drug Delivery 2
-
- Protein purification and stability 4
-
- Pain Mechanisms and Treatments 1
-
- Analytical Chemistry and Chromatography 1
-
- Antimicrobial agents and applications 1
- Co-authors
- Karthik Yadav JangaSandeep SarabuNarendar DudhipalaArun ButreddyS. Narasimha MurthyPrit LakhaniMichael A. RepkaBalaram Ghosh
- Journals
- International Journal of Pharmaceutics (3 papers)Journal of Pharmaceutical Sciences (1 paper)International Journal of Biological Macromolecules (1 paper)
- Partner nations
- United StatesIndiaBangladesh
In The Last Decade
Srinivas Ajjarapu
13 papers receiving 345 citations
Peers
Comparison fields: 5 of 92
- Pharmaceutical Science 127
- Drug Discovery 1
- Biomaterials 51
- Molecular Medicine 19
- Food Science 47
Countries citing papers authored by Srinivas Ajjarapu
This map shows the geographic impact of Srinivas Ajjarapu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Srinivas Ajjarapu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Srinivas Ajjarapu more than expected).
Fields of papers citing papers by Srinivas Ajjarapu
This network shows the impact of papers produced by Srinivas Ajjarapu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Srinivas Ajjarapu. The network helps show where Srinivas Ajjarapu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Srinivas Ajjarapu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 16 | |
| 2 | 2023 | 17 | |
| 3 | 2023 | 8 | |
| 4 | 2022 | 6 | |
| 5 | 2021 | 14 | |
| 6 | 2021 | 12 | |
| 7 | 2021 | 18 | |
| 8 | 2020 | 13 | |
| 9 | 2020 | 12 | |
| 10 | 2020 | 101 | |
| 11 | 2019 | 32 | |
| 12 | 2017 | 73 | |
| 13 | 2016 | 42 |
About Srinivas Ajjarapu
Srinivas Ajjarapu is a scholar working on Pharmaceutical Science, Molecular Medicine and Biomaterials, having authored 13 papers that have together received 364 indexed citations. Recurring topics across this work include Drug Solubulity and Delivery Systems (4 papers), Protein purification and stability (4 papers), Advancements in Transdermal Drug Delivery (3 papers), Nanoparticle-Based Drug Delivery (2 papers), Advanced Drug Delivery Systems (2 papers), Pain Mechanisms and Treatments (1 paper), Analytical Chemistry and Chromatography (1 paper) and Antimicrobial agents and applications (1 paper). The work is most often cited by research in Pharmaceutical Science (127 citations), Drug Discovery (1 citation) and Biomaterials (51 citations). Srinivas Ajjarapu has collaborated with scholars based in United States, India and Bangladesh. Frequent co-authors include Karthik Yadav Janga, Sandeep Sarabu, Narendar Dudhipala, Arun Butreddy, S. Narasimha Murthy, Prit Lakhani, Michael A. Repka, Balaram Ghosh, Swati Biswas and Kai-Wei Wu. Their work appears in journals such as International Journal of Pharmaceutics, Journal of Pharmaceutical Sciences and International Journal of Biological Macromolecules.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.